CRP and hepatocellular carcinoma: Studies conducted by Kinoshita et al. [43], Chen et al. [44], and Li et al. [45] revealed that a high pre-treatment serum CRP/ALB ratio was independently correlated with worse OS and RFS in HCC patients treated with curative surgical resection, RFA, PEI, or TACE.